← All companies

BRNS

Barinthus Biotherapeutics plc

BRNS Nasdaq Pharmaceutical Preparations EDGAR ↗

$0.60

+0.04 +7.51%

Key statistics

from XBRL data in SEC filings

Market cap

$24.5M

Revenue (TTM)

$0.00

Net income (TTM)

-$52.3M

EPS (TTM)

$-1.29

P/E ratio

—

Dividend yield

—

Free cash flow

-$48.0M

Cash

$65.9M

Total assets

$92.1M

Gross margin

—

52-week range

$0.51 – $1.83

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results; Other events Jul 2, 2026 8-K Shareholder vote results May 21, 2026 10-Q Quarter ended 2026-03-31 Apr 30, 2026 8-K Results of operations (earnings release) Apr 30, 2026 8-K Director or officer change Apr 22, 2026 8-K Director or officer change Mar 31, 2026 10-K Fiscal year ended 2025-12-31 Mar 13, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 13, 2026 8-K Entered a material agreement Feb 23, 2026 8-K Delisting notice or listing-rule failure Jan 6, 2026 8-K Regulation FD disclosure Dec 10, 2025 10-Q Quarter ended 2025-09-30 Nov 7, 2025 8-K Results of operations (earnings release) Nov 7, 2025 8-K Entered a material agreement; Regulation FD disclosure Sep 30, 2025 8-K/A Results of operations (earnings release) Aug 8, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Shareholder vote results Jun 10, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure; Other events May 7, 2025 10-K Fiscal year ended 2024-12-31 Mar 20, 2025 8-K Results of operations (earnings release) Mar 20, 2025 8-K Results of operations (earnings release); Exit or disposal costs; Director or officer change; Regulation FD disclosure Jan 10, 2025 8-K Director or officer change; Other events Nov 25, 2024 8-K Regulation FD disclosure; Other events Nov 15, 2024 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release) Nov 6, 2024 8-K Director or officer change Sep 5, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Other events Jun 12, 2024 8-K Regulation FD disclosure; Other events Jun 6, 2024 8-K Shareholder vote results May 15, 2024 8-K/A Results of operations (earnings release); Regulation FD disclosure May 14, 2024 10-Q Quarter ended 2024-03-31 May 13, 2024 8-K Results of operations (earnings release) May 13, 2024 8-K Other events Apr 18, 2024 10-K Fiscal year ended 2023-12-31 Mar 20, 2024 8-K Results of operations (earnings release) Mar 20, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Jan 5, 2024